Iran Develops Revolutionary Diagnostic Radiopharmaceutical: Nuclear Chief
TEHRAN (Tasnim) – Iran has produced a radiopharmaceutical used for diagnosing 30 types of cancer, Head of the Atomic Energy Organization of Iran (AEOI) Mohammad Eslami said.
Addressing worshippers at the Friday prayers of Tehran on April 11, Eslami said the Iranian scientists have developed a radiopharmaceutical that is capable of diagnosing 30 types of cancer.
Apart from Iran, only one or two other countries have the technical know-how to produce that diagnostic pharmaceutical, he said.
In December 2022, the AEOI chief said Iran aims to become a global hub for manufacturing deuterium drugs.
“In a not too distant future we will turn into a hub for manufacturing drugs based on deuterium which are good alternatives to chemical drugs and have lower side effects in comparison (to those drugs),” he stated.
The AEOI launched a second phase of its deuterium production unit in Arak Heavy Water Reactor Facility in central Iran in April 2021.
